BRIEF published on 05/19/2026 at 07:05, 9 days 2 hours ago Innate Pharma at the Jefferies Global Healthcare Conference Immunotherapy Cancer Innate Pharma Therapeutic Antibodies Jefferies Conference
BRIEF published on 05/19/2026 at 07:05, 9 days 2 hours ago Innate Pharma à la Conférence Jefferies Global Healthcare Immunothérapie Cancer Innate Pharma Conférence Jefferies Anticorps Thérapeutiques
BRIEF published on 05/19/2026 at 07:05, 9 days 2 hours ago Innate Pharma participera à la conférence mondiale sur les soins de santé de Jefferies Biotechnologie Immunothérapie Traitement Du Cancer Innate Pharma Conférence Jefferies
BRIEF published on 05/19/2026 at 07:05, 9 days 2 hours ago Innate Pharma to Attend Jefferies Global Healthcare Conference Biotechnology Cancer Treatment Immunotherapy Innate Pharma Jefferies Conference
PRESS RELEASE published on 05/19/2026 at 07:00, 9 days 3 hours ago Informations privilégiées / Autres communiqués Innate Pharma participera à la conférence Jefferies Global Healthcare 2026 à New York. La société de biotechnologies développe des traitements d'immunothérapies contre le cancer Conference Cancer Innate Pharma Biotechnologies Immunothérapies
PRESS RELEASE published on 05/19/2026 at 07:00, 9 days 3 hours ago Inside Information / Other news releases Innate Pharma to participate in Jefferies Global Healthcare Conference on June 2-4, 2026 in New York, United States. Developing immunotherapies for cancer patients Biotechnology Innate Pharma Jefferies Global Healthcare Conference Immunothérapies Cancer Patients
BRIEF published on 04/17/2026 at 21:05, 1 month 10 days ago Innate Pharma presents interim results from the MATISSE trial at the AACR congress Lung Cancer Innate Pharma AACR 2026 IPH5201 Phase 2 MATISSE
BRIEF published on 04/17/2026 at 21:05, 1 month 10 days ago Innate Pharma Reveals Promising Interim Results in MATISSE Phase 2 Study Clinical Trials Lung Cancer Innate Pharma MATISSE Phase 2 IPH5201
BRIEF published on 04/17/2026 at 21:05, 1 month 10 days ago Innate Pharma dévoile des résultats intermédiaires prometteurs dans l'étude de phase 2 MATISSE Essais Cliniques Cancer Du Poumon Innate Pharma MATISSE Phase 2 IPH5201
BRIEF published on 04/17/2026 at 21:05, 1 month 10 days ago Innate Pharma présente des résultats intermédiaires de l'essai MATISSE au congrès AACR Cancer Du Poumon Innate Pharma AACR 2026 IPH5201 Phase 2 MATISSE
Published on 05/28/2026 at 09:05, 59 minutes ago Tocvan Intersects Three New Gold-Silver Zones at Gran Pilar Project Exploration Drilling; Provides Pilot Mine Development Update
Published on 05/28/2026 at 09:01, 1 hour 3 minutes ago Discovery Energy Metals Corp. Mobilizes Crews for Surface Sampling Program at Crystal Lake Cu-Mo Project, British Columbia
Published on 05/28/2026 at 09:00, 1 hour 4 minutes ago Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th
Published on 05/28/2026 at 08:00, 2 hours 4 minutes ago Touchstone Exploration Provides An Operational Update
Published on 05/28/2026 at 09:45, 19 minutes ago Powering Macau's Smart Future with AI —MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo
Published on 05/28/2026 at 09:30, 34 minutes ago Topadur Pharma AG Adds Senior Board Expertise with Appointment of Dr. Felix R. Ehrat and Dr. Peter Jager
Published on 05/28/2026 at 09:30, 34 minutes ago M2care and ZEISS Ventures Support Maculaser Oy to Advance Pioneering Temperature-Controlled Retinal Laser Therapy
Published on 05/28/2026 at 09:30, 34 minutes ago M2care et ZEISS Ventures soutiennent Maculaser Oy pour accélérer le développement d’une thérapie laser rétinienne innovante à contrôle de température
Published on 05/28/2026 at 09:19, 44 minutes ago u-blox expands collaboration with Nordic Semiconductor, introducing ALMA-B2 modules with low-latency Edge ML capabilities
Published on 05/28/2026 at 08:45, 1 hour 19 minutes ago Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/28/2026 at 08:45, 1 hour 19 minutes ago Nomination de Mikael Frenkian en qualité de Directeur Général de Baikowski
Published on 05/28/2026 at 08:30, 1 hour 34 minutes ago Cegedim Business Services renforce sa conformité et sa sécurité avec deux distinctions majeures
Published on 05/27/2026 at 23:00, 11 hours 4 minutes ago BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Published on 05/27/2026 at 23:00, 11 hours 4 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
